Research themes and advances in malaria research capacity made by the Multilateral Initiative on Malaria

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue SUPPL. 6, 2007, Pages 303-313

  Nantulya, Florence N ^b   Kengeya Kayondo, Jane F ^a   Ogundahunsi, Olumide A T ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ANIMAL; ECONOMICS; HUMAN; INTERNATIONAL COOPERATION; MALARIA; PARASITOLOGY; RESEARCH; REVIEW;

AFRICA; ANIMALS; HUMANS; INTERNATIONAL COOPERATION; MALARIA; RESEARCH;

EID: 40049110044     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Bruno JM, Feachem R, Godal T, Nchinda T, Ogilvie B, Mons B, Mshana R, Radda G, Samba E, Schwartz M, Varmus H, Diallo S, Doumbo O, Greenwood B, Kilama W, Miller LH, da Silva LP, 1997. The spirit of Dakar: a call for action on malaria. Nature 386: 541.
2. Davies CS, 1999. The Multilateral Initiative on Malaria: coordination and co-operation in international malaria research. Parassitologia 41: 497-500.
3. Scholtens RG, Kaiser RL, Langmuir AD, 1972. An epidemiologic examination of the strategy of malaria eradication. Int J Epidemiol 1: 15-24.
4. Nabarro D, 1999. Roll Back Malaria. Parassitologia 41: 501-504.
5. MARDA, 2005. Malaria R & D Alliance Assessment of Global Investment. [cited September 2007]. Available from www.malariaalliance.org.
6. Shiffman J, 2006. Donor funding priorities for communicable disease control in the developing world. Health Policy Plan 21: 411-420.
7. Alilio MS, Bygbjerg IBC, Breman JG, 2004. Are multilateral malaria research and control programs the most successful? Lesson from the past 100 years in Africa. Am J Trop Med Hyg 71: 268-278.
8. Heddini A, Keusch GT, Davies CS, 2004. The multilateral initiative on malaria: past, present, and future. Am J Trop Med Hyg 71: 279-282.
9. WHO/TDR 1998. Multilateral perspective on malaria begins to take shape. TDR News Feb: 1, 12.
10. Zicker F, 2001. Strengthening capability for malaria research in Africa. Emerg Infect Dis 7: 529-530.
11. Beattie P, Renshaw M, Davies CS, 1999. Strengthening Health Research in the Developing World. Malaria Research Capacity in Africa. London: The Trustee of the Wellcome Trust.
12. Bockarie M, Bond E, Mutambu S, Nchinda T, Quakyi I, Rodriguez-Lopez M, Snow R, 2002. Review of the Multilateral Initiative on Malaria (MIM). [cited September 2007]. Available from www.fic.nih.gov/about/plan/mim-final.pdf.
13. WHO/TDR 2003. Report of the Scientific Working Group on Malaria. [cited September 2007]. Available from www.who.int/tdr/publications/publications/ malaria-swg.htm.
14. Breman JG, Mills A, Snow RW, Mulligan J, Lengeler C, Mendis K, Sharp B, Morel C, Machesini P, White NJ, Steketee RW, Doumbo OK, 2006. Conquering malaria. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, eds. Disease Control Priorities in Developing Countries. Second edition. New York: Oxford University Press, 413-431.
15. Akanmori BD, Kurtzhals JA, Goka BQ, Adabayeri V, Ofori MF, Nkrumah FK, Behr C, Hviid L, 2000. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw 11: 113-118.
16. Ekala MT, Lekoulou F, Djikou S, Dubreuil G, Issifou S, Ntoumi F, 2000. Evaluation d'une méthode simple et rapide d'extraction de l'ADN de Plasmodium falciparum à partir de gouttes épaisses de patients gabonais. Bull Soc Pathol Exot 93: 8-11.
17. Quaye IK, Ekuban FA, Goka BQ, Adabayeri V, Kurtzhals JA, Gyan B, Ankrah NA, Hviid L, Akanmori BD, 2000. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 94: 216-219.
18. Goka BQ, Kwarko H, Kurtzhals JA, Gyan B, Ofori-Adjei E, Ohene SA, Hviid L, Akanmori BD, Neequaye J, 2001. Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 95: 545-549.
19. Issifou S, Ndikou S, Sanni A, Lekoulou F, Ntoumi F, 2001. No influence of the transmission season on genetic diversity and complexity of infections in Plasmodium falciparum isolates from Benin. Afr J Med Med Sci 30: 17-20.
20. Ntoumi F, Ngoundou-Landji J, Luty A, Dubreuil G, Millet P, 2001. Polymorphisme allélique du gène MSP-2 de Plasmodium falciparum analysé à partir d'échantillons sanguins d'enfants gabonais. Bull Soc Pathol Exot 94: 183-187.
21. Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F, 2002. Plasmodium falciparum merozoite surface protein 1 (PfMSP1): genotyping and humoral responses to allele-specific variants. Acta Trop 81: 33-46.
22. Ekala MT, Jouin H, Lekoulou F, Mercereau-Puijalon O, Ntoumi F, 2002. Allelic Family specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections. Clin Exp Immunol 129: 326-331.
23. Gyan B, Goka B, Cvetkovic JT, Perlmann H, Lefvert AK, Akanmori B, Troye-Blomberg M, 2002. Polymorphisms in interleukin-1 and interleukin-1 receptor antagonist genes and malaria in Ghanaian children. Scand J Immunol 56: 619-622.
24. Gyan B, Kurtzhals JA, Akanmori BD, Ofori M, Goka BQ, Hviid L, Behr C, 2002. Elevated levels of nitric oxide and low levels of haptoglobin are associated with severe malarial anaemia in African children. Acta Trop 83: 133-140.
25. Kemp K, Akanmori BD, Adabayeri V, Goka BQ, Kurtzhals JA, Behr C, Hviid L, 2002. Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria. Clin Exp Immunol 127: 151-157.
26. Ntoumi F, Ekala MT, Makuwa M, Lekoulou F, Mercereau-Puijalon O, Deloron P, 2002. Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children. Immunol Lett 84: 9-16.
27. Nwuba RI, Sodeinde O, Anumudu CI, Omosun YO, Odaibo AB, Holder AA, Nwagwu M, 2002. The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. Infect Immun 70: 5328-5331.
28. Issifou S, Mavoungou E, Borrmann S, Bouyou-Akotet MK, Matsiegui PB, Kremsner PG, Ntoumi F, 2003. Severe malarial anemia associated with increased soluble Fas ligand (sFasL) concentration in Gabonese children. Eur Cytokine Netw 14: 238-241.
29. Issifou S, Rogier C, Adjagba-Olakpo M, Chabi-Worou N, Ntoumi F, 2003. Complexity and genetic diversity of Plasmodium falciparum infections in young children living in urban areas of central and west Africa. Parasitol Res 90: 423-428.
30. Mawili-Mboumba DP, Borrmann S, Cavanagh DR, McBride JS, Matsiegui PB, Missinou MA, Kremsner PG, Ntoumi F, 2003. Antibody responses to P. falciparum MSP-1 and the efficacy of amodiaquine in Gabonese children with falciparum malaria. J Infect Dis 187: 1137-1141.
31. Anumudu CI, Okafor CM, Ngwumohaike V, Afolabi KA, Nwuba RI, Nwagwu M, 2004. Clinical manifestations and immune response to MSP 1(19) in severe paediatric malaria in Adeoyo state maternity hospital, Ibadan. Afr J Med Med Sci 33: 57-63.
32. Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V, Perlmann H, Lefvert AK, Akanmori BD, Troye-Blomberg M, 2004. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin Exp Immunol 138: 145-150.
33. Mayengue PI, Rieth H, Khattab A, Issifou S, Kremsner PG, Klinkert M, Ntoumi F, 2004. Submicroscopic Plasmodium falciparum infections and multiplicity of infection in matched peripheral, placental and umbilical cord blood samples from Gabonese women. Trop Med Int Health 9: 949-958.
34. Akum AE, Kuoh AJ, Minang JT, Achimbom BM, Ahmadou MJ, Troye-Blomberg M, 2005. The effect of maternal, umbilical cord and placental malaria parasitaemia on the birthweight of newborns from south-western Cameroon. Acta Paediatr 94: 917-923.
35. Akum AE, Minang JT, Kuoh AJ, Ahmadou MJ, Troye-Blomberg M, 2005. Plasmodium falciparum inhibitory capacities of paired maternal-cord sera from south-west province,Cameroon. J Trop Pediatr 51: 182-190.
36. Achidi EA, Anchang JK, Minang JT, Ahmadou MJ, Troye-Blomberg M, 2005. Studies on Plasmodium falciparum isotypic antibodies and numbers of IL-4 and IFN-gamma secreting cells in paired maternal cord blood from south west Cameroon. Int J Infect Dis 9: 159-169.
37. Achidi EA, Kuoh AJ, Minang JT, Ngum B, Achimbom BM, Motaze SC, Ahmadou MJ, Troye-Blomberg M, 2005. Malaria infection in pregnancy and its effects on haemoglobin levels in women from a malaria endemic area of Fako Division, South West Province, Cameroon. J Obstet Gynaecol 25: 235-240.
38. Amodu OK, Adeyemo AA, Ayoola OO, Gbadegesin RA, Orimadegun AE, Akinsola AK, Olumese PE, Omotade OO, 2005. Genetic diversity of the msp-1 locus and symptomatic malaria in south-west Nigeria. Acta Trop 95: 226-232.
39. Amodu OK, Gbadegesin RA, Ralph SA, Adeyemo AA, Brenchley PE, Ayoola OO, Orimadegun AE, Akinsola AK, Olumese PE, Omotade OO, 2005. Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Acta Trop 95: 248-255.
40. Amodu OK, Olumese PE, Gbadegesin RA, Ayoola OO, Adeyemo AA, 2006. The influence of individual preventive measures on the clinical severity of malaria among Nigerian children. Acta Trop 97: 370-372.
41. Boeuf P, Vigan-Womas I, Jublot D, Loizon S, Barale JC, Akanmori BD, Mercereau-Puijalon O, Behr C, 2005. CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6: 5.
42. Minang JT, Gyan BA, Anchang JK, Troye-Blomberg M, Perlmann H, Achidi EA, 2004. Haptoglobin phenotypes and malaria infection in pregnant women at delivery in western Cameroon. Acta Trop 90: 107-114.
43. Ntoumi F, Flori L, Mayengue PI, Matondo Maya DW, Issifou S, Deloron P, Lell B, Kremsner PG, Rihet P, 2005. Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children. J Infect Dis 192: 1975-1980.
44. Omosun YO, Anumudu CI, Adoro S, Odaibo AB, Sodeinde O, Holder AA, Nwagwu M, Nwuba RI, 2005. Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons. Acta Trop 95: 233-247.
45. Rasti N, Falk KI, Donati D, Gyan BA, Goka BQ, Troye-Blomberg M, Akanmori BD, Kurtzhals JA, Dodoo D, Consolini R, Linde A, Wahlgren M, Bejarano MT, 2005. Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol 61: 461-465.
46. Awandare GA, Goka B, Boeuf P, Tetteh JK, Kurtzhals JA, Behr C, Akanmori BD, 2006. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J Infect Dis 194: 1438-1446.
47. Haase R, Megnekou R, Lundquist M, Ofori MF, Hviid L, Staalsoe T, 2006. Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo. Infect Immun 74: 3035-3038.
48. Matondo Maya DW, Mavoungou E, Deloron P, Theisen M, Ntoumi F, 2006. Distribution of IgG subclass antibodies specific for Plasmodium falciparum glutamate-rich-protein molecule in sickle cell trait children with asymptomatic infections. Exp Parasitol 112: 92-98.
49. Rindsjo E, Hulthen Varli I, Ofori MF, Lundquist M, Holmlund U, Papadogiannakis N, Scheynius A, 2006. Presence of IgE cells in human placenta is independent of malaria infection or chorioamnionitis. Clin Exp Immunol 144: 204-211.
50. Achidi EA, Apinjoh TO, Titanji VP, 2007. Malaria parasitemia and systemic cytokine bias in pregnancy. Int J Gynaecol Obstet 97: 15-20.
51. Mavoungou E, Held J, Mewono L, Kremsner PG, 2007. A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. J Infect Dis 195: 1521-1531.
52. Mayengue PI, Kalmbach Y, Issifou S, Kremsner PG, Ntoumi F, 2007. No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria. Parasitol Res 100: 489-493.
53. Meraldi V, Nebie I, Tiono AB, Diallo D, Sanogo E, Theisen M, Druilhe P, Corradin G, Moret R, Sirima BS, 2004. Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol 26: 265-272.
54. Collins FH, Kamau L, Ranson HA, Vulule JM, 2000. Molecular entomology and prospects for malaria control. Bull World Health Organ 78: 1412-1423.
55. Dia I, Loucouarn L, Boccolini D, Constantini C, Fontenille D, 2000. Spatial and temporal variations of the chromosomal inversion polymorphism of Anopheles funestus in Senegal. Parasite 7: 179-184.
56. Ranson H, Jensen B, Vulule JM, Wang X, Hemingway J, Collins FH, 2000. Identification of a point mutation in the voltagegated sodium channel gene of Kenyan Anopheles gambiae associated with resistance to DDT and pyrethroids. Insect Mol Biol 9: 491-497.
57. Sinkins SP, Hackett BJ, Costantini C, Vulule J, Ling YY, Collins FH, Besansky NJ, 2000. Isolation of polymorphic microsatellite loci from the malaria vector Anopheles funestus. Mol Ecol 9: 490-492.
58. Weill M, Chandre F, Brengues C, Manguin S, Akogbeto M, Pasteur N, Guillet P, Raymond M, 2000. The kdr mutation occurs in the Mopti form of Anopheles gambiae s.s. through introgression. Insect Mol Biol 9: 451-455.
59. Diabaté A, Brengues C, Baldet T, Dabire KR, Hougard JM, Akogbeto M, Kengne P, Simard F, Guillet P, Hemingway J, Chandre F, 2004. The spread of the Leu-Phe kdr mutation through Anopheles gambiae complex in Burkina Faso: genetic introgression and de novo phenomena. Trop Med Int Health 9: 1267-1273.
60. Awolola TS, Oyewole IO, Amajoh CN, Idowu ET, Ajayi MB, Oduola A, Manafa OU, Ibrahim K, Koekemoer LL, Coetzee M, 2005. Distribution of the molecular forms of Anopheles gambiae and pyrethroid knock down resistance gene in Nigeria. Acta Trop 95: 204-209.
61. Awolola TS, Oyewole IO, Koekemoer LL, Coetzee M, 2005. Identification of three members of the Anopheles funestus (Diptera: Culicidae) group and their role in malaria transmission in two ecological zones in Nigeria. Trans R Soc Trop Med Hyg 99: 525-531.
62. Akogbeto MC, Djouaka RF, Kinde-Gazard DA, 2006. Screening of pesticide residues in soil and water samples from agricultural settings. Malar J 5: 22-30.
63. Crawley J, Kokwaro G, Ouma D, Watkins W, Marsh K, 2000. Chloroquine is not a risk factor for seizure in childhood cerebral malaria. Trop Med Int Health 5: 860-864.
64. Mberu EK, Mosobo M, Nzila MA, Kokwaro GO, Sibley C, Watkins WM, 2000. The changing pattern of in vitro response to pyrimethamine-sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Am J Trop Med Hyg 62: 396-401.
65. Ogutu BR, Newton CR, Crawley J, Muchohi SN, Otieno GO, Edwards G, Marsh K, Kokwaro GO, 2002. Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. Br J Clin Pharmacol 53: 49-57.
66. Ogutu BR, Newton CR, Muchohi SN, Otieno GO, Kokwaro GO, 2002. Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration. Br J Clin Pharmacol 54: 635-642.
67. Oundo JO, Muli F, Kariuki S, Waiyaki PG, Iijima Y, Berkley J, Kokwaro G, Ngetsa CJ, Mwarumba S, Torto R, Lowe B, 2002. Association of non-typhi Salmonella with severe malaria in children in Kilifi on the Kenyan coast. E Afr Med J 79: 633-638.
68. Barennes H, Sterlingot H, Nagot N, Meda H, Kabore M, Sanou M, Nacro B, Bouree P, Pussard E, 2003. Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria. Eur J Clin Pharmacol 58: 649-652.
69. Djimdé AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV, 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69: 558-563.
70. Kokwaro GO, Ogutu BR, Muchohi SN, Otieno GO, Newton CR, 2003. Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions. Br J Clin Pharmacol 56: 453-457.
71. Nzila MA, Mberu KE, Bray P, Kokwaro G, Ward S, Watkins B, Winstanley P, Marsh K, 2003. Reversal of antifolate and chloroquine resistance by probenecid in Plasmodium falciparum. Antimicrob Agents Chemother 47: 2108-2112.
72. Muchohi SN, Kokwaro GO, Maitho TE, Munenge RW, Watkins WM, Edwards IG, 2002. Pharmacokinetics of phenytoin and fosphenytoin following intravenous and intramuscular administration. Eur J Pharmacokin Biopharm 27: 83-89.
73. Ogutu BR, Newton CR, Muchohi SN, Otieno GO, Edwards G, Watkins WM, Kokwaro GO, 2003. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus. Br J Clin Pharmacol 56: 112-119.
74. Thompson AH, Kokwaro GO, English M, Muchohi S, Mohammed S, Edwards IG, 2003. Population pharmacokinetics of intramuscular gentamicin administered to infants with suspected sepsis in Kenya. Br J Clin Pharmacol 56: 25-31.
75. Gitau EN, Muchohi SN, Ogutu BR, Githiga IM, Kokwaro G, 2004. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. J Chromatograph 799: 173-177.
76. Mithwani S, Aarons L, Kokwaro GO, Majid O, Muchohi S, Edwards G, Mohamed S, Marsh K, Watkins W, 2004. Population pharmacokinetics of artemether and dihydroartemisinin following intramuscular administration to children with severe malaria. Br J Clin Pharmacol 57: 148-152.
77. Nzila A, Kokwaro G, Winstanley P, Marsh K, Ward S, 2004. Can exploitation of the folate salvage pathway in Plasmodium falciparum be the saviour of sulfadoxine/pyrimethamine? Trends Parasitol 20: 109-111.
78. Achidi EA, Ajua A, Kimbi HK, Sinju CM, 2005. In vivo efficacy study of quinine sulphate in the treatment of uncomplicated P. falciparum malaria in patients from southwestern Cameroon. East Afr Med J 82: 181-185.
79. Akogun OB, John KK, 2005. Illness-related practices for the management of childhood malaria among the Bwatiye people of north-eastern Nigeria. Malar J 4: 13.
80. Koram KA, Abuaku B, Duah N, Quashie N, 2005. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop 95: 194-203.
81. Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, Beck HP, Genton B, 2005. Efficacy of sulfadoxinepyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J 4: 55.
82. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Bamgboye AE, Babalola CP, Happi TC, Gbotosho GO, 2005. Effects of antifolates-co-trimoxazole and pyrimethamine-sulfadoxine-on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 100: 451-455.
83. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Gbotosho GO, Happi TC, Tambo E, Oduola AM, 2005. Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated, Plasmodium falciparum malaria, in an area with high and increasing incidences of chloroquine resistance. Ann Trop Med Parasitol 99: 535-544.
84. Quashie NB, Duah NO, Abuaku B, Koram KA, 2007. The invitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs. Ann Trop Med Parasitol 101: 391-398.
85. Mawili-Mboumba DP, Ekala MT, Lekoulou F, Ntoumi F, 2001. Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut-Ogooue region in Gabon. Acta Trop 78: 231-240.
86. Mawili-Mboumba D, Kun JFJ, Lell B, Kremsner PG, Ntoumi F, 2002. Pfmdr1 gene alleles and response to low dose mefloquine treatment in Gabonese patients. Antimicrob Agents Chemother 46: 166-170.
87. Mberu EK, Nzila AM, Nduati E, Ross A, Monks SM, Kokwaro GO, Watkins WM, Hopkins Sibley C, 2002. Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Exp Parasitol 101: 90-96.
88. Happi TC, Thomas SM, Gbotosho GO, Falade CO, Akinboye DO, Gerena L, Hudson T, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM, 2003. Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann Trop Med Parasitol 97: 439-451.
89. Ochong E, Nzila A, Kimani S, Kokwaro G, Mutabingwa T, Watkins W, Marsh K, 2003. Molecular monitoring of Leu-164 mutation of dihydrofolate reductase in highly sulfadoxine/pyrimethamine-resistant area in Africa. Malar J 2: 46.
90. Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H, 2004. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Am J Trop Med Hyg 71: 696-702.
91. Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM, 2005. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxinepyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop 95: 183-193.
92. Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F, 2005. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Congo. Acta Trop 95: 219-225.
93. Sibley CH, Barnes KI, Plowe CV, 2007. The rationale and plan for creating a World Antimalarial Resistance Drug Network (WARN). Malar J 6: 118.
94. Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ, 2007. World Antimalarial Resistance Network (WARN) I: clinical efficacy of antimalarial therapy. Malar J 6: 119.
95. Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichchanalai C, Fukuda MM, Ringwald P, Sibley CH, Kyle DE, 2007. World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. Malar J 6: 120.
96. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ, 2007. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J 6: 121.
97. Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ, 2007. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Malar J 6: 122.
98. World Health Organization, 2006. Treatment of Uncomplicated P. falciparum malaria. Guidelines for the Treatment of Malaria. Geneva: World Health Organization, 16-40.
99. Ajayi IO, Falade CO, Adeniyi JD, Bolaji MO, 2003. The role of patent medicine sellers in home management of childhood malaria: a situational anaysis of experience in rural Nigeria. Int Q Community Health Educ 21: 271-281.
100. Asa A, Adegbenro CA, Dare FO, Adeniyi JD, Osowole OS, Oladepo O, 2004. Enhancing treatment compliance in the home management of childhood malaria: the use of a participatory approach in ensuring intervention appropriateness. Int Q Community Health Educ 22: 239-248.
101. Falade CO, Osowole OS, Adeniyi JD, Oladepo O, 2004. Attitude of health care workers to the involvement of alternative healthcare providers in the home management of childhood malaria. Int Q Community Health Educ 23: 169-180.
102. Falade CO, Ogundiran MO, Bolaji MO, Ajayi IO, Akinboye DO, Oladepo O, Adeniyi JD, Oduola AM, 2005. The influence of cultural perception of causation, complications, and severity of childhood malaria on determinants of treatment and preventive pathways. Int Q Community Health Educ 24: 347-363.
103. Ajaiyeoba EO, Abalogu UI, Krebs HC, And Oduola AMJ, 1999. In vivo antimalarial activities of Quassia amara and Quassia undulate plant extracts in mice. J Ethnopharmacol 67: 321-325.
104. Barasa SS, Ndiege IO, Lwande W, Hassanali A, 2002. Repellent activities of stereoisomers of p-menthane-3,8-diols against Anopheles gambiae (Diptera: Culicidae). J Med Entomol 39: 736-741.
105. Seyoum A, Kabiru EW, Lwande W, Killeen GF, Hassanali A, Knols BG, 2002. Repellency of live potted plants against Anopheles gambiae from human baits in semi-field experimental huts. Am J Trop Med Hyg 67: 191-195.
106. Seyoum A, Killeen GF, Kabiru EW, Knols BG, Hassanali A, 2003. Field efficacy of thermally expelled or live potted repellent plants against African malaria vectors in western Kenya. Trop Med Int Health 8: 1005-1011.
107. Seyoum A, Palsson K, Kung'a S, Kabiru EW, Lwande W, Killeen GF, Hassanali A, Knols BG, 2002. Traditional use of mosquito-repellent plants in western Kenya and their evaluation in semi-field experimental huts against Anopheles gambiae: ethnobotanical studies and application by thermal expulsion and direct burning. Trans R Soc Trop Med Hyg 96: 225-231.
108. Ajaiyeoba EO, Oladepo O, Fawole OI, Bolaji OM, Akinboye DO, Ogundahunsi OA, Falade CO, Gbotosho GO, Itiola OA, Happi TC, Ebong OO, Ononiwu IM, Osowole OS, Oduola OO, Ashidi JS, Oduola AM, 2003. Cultural categorization of febrile illnesses in correlation with herbal remedies used for treatment in southwestern Nigeria. J Ethnopharmacol 85: 179-185.
109. Ndung'u M, Hassanali A, Hooper AM, Chhabra S, Miller TA, Paul RL, Torto B, 2003. Ring A-seco mosquito larvicidal limonoids from Turraea wakefieldii. Phytochemistry 64: 817-823.
110. Ajaiyeoba EO, Falade CO, Fawole OI, Akinboye DO, Gbotosho GO, Bolaji OM, Ashidi JS, Abiodun OO, Osowole OS, Itiola OA, Oladepo O, Sowunmi A, Oduola AM, 2004. Efficacy of herbal remedies used by herbalists in Oyo State Nigeria for treatment of Plasmodium falciparum infections: a survey and an observation. Afr J Med Med Sci 33: 115-119.
111. Omolo MO, Okinyo D, Ndiege IO, Lwande W, Hassanali A, 2004. Repellency of essential oils of some Kenyan plants against Anopheles gambiae. Phytochemistry 65: 2797-2802.
112. Odalo JO, Omolo MO, Malebo H, Angira J, Njeru PM, Ndiege IO, Hassanali A, 2005. Repellency of essential oils of some plants from the Kenyan coast against Anopheles gambiae. Acta Trop 95: 210-218.
113. Omolo MO, Okinyo D, Ndiege IO, Lwande W, Hassanali A, 2005. Fumigant toxicity of the essential oils of some African plants against Anopheles gambiae sensu stricto. Phytomedicine 12: 241-246.
114. Kleinschmidt I, Omumbo J, Briêt O, van de Giesen N, Sogoba N, Kumasenu Mensah N, Windmeijer P, Moussa M, Teuscher T, 2001. An empirical malaria distribution map for west Africa. Trop Med Int Health 6: 779-786.
115. Ntoumi F, Djimde AA, Mbacham W, Egwang T, 2004. The importance and future of malaria research in Africa. Am J Trop Med Hyg 71: iv.